Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1973

1.

Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.

Cobo-Calvo Á, Sepúlveda M, Bernard-Valnet R, Ruiz A, Brassat D, Martínez-Yélamos S, Saiz A, Marignier R.

Mult Scler. 2015 Jul 24. pii: 1352458515591071. [Epub ahead of print]

PMID:
26209592
2.

Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.

Pekcevik Y, Mitchell CH, Mealy MA, Orman G, Lee IH, Newsome SD, Thompson CB, Pardo CA, Calabresi PA, Levy M, Izbudak I.

Mult Scler. 2015 Jul 24. pii: 1352458515591069. [Epub ahead of print]

PMID:
26209588
3.

B Cells and Autoantibodies in Multiple Sclerosis.

Pröbstel AK, Sanderson NS, Derfuss T.

Int J Mol Sci. 2015 Jul 21;16(7):16576-92. doi: 10.3390/ijms160716576. Review.

4.

[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].

Yun W, Weihua Z, Xiaotun R, Jiuwei L, Xinying Y, Junlan L, Changhong D, Chunhong C, Haitao R, Liying C, Fang F.

Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):268-73. Chinese.

PMID:
26182501
5.

The Etiological Spectrum of Acute Sensory Myelitis.

Hyun JW, Kim JY, Choi KG, Kim HJ, Park KD.

J Clin Neurol. 2015 Jul;11(3):227-33. doi: 10.3988/jcn.2015.11.3.227.

6.

Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience.

Jagtap SA, Mandliya A, Sarada C, Nair MD.

J Neurosci Rural Pract. 2015 Jul-Sep;6(3):331-5. doi: 10.4103/0976-3147.158755.

7.

Profile of neuromyelitis optica and spectrum disorders in an Indian cohort.

Koudriavtseva T, Renna R.

J Neurosci Rural Pract. 2015 Jul-Sep;6(3):295-6. doi: 10.4103/0976-3147.158734. No abstract available.

8.

Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.

Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, Vucic S, Gorman MP, Benson LA, Alper G, Riney CJ, Barnett M, Parratt J, Hardy TA, Leventer RJ, Merheb V, Nosadini M, Fung VS, Brilot F, Dale RC.

Mult Scler. 2015 Jul 10. pii: 1352458515593406. [Epub ahead of print]

PMID:
26163068
9.

[Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus].

Mori M.

Brain Nerve. 2015 Jul;67(7):881-90. doi: 10.11477/mf.1416200227. Japanese.

PMID:
26160816
10.

Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil.

Papais-Alvarenga RM, Pereira FF, Bernardes MS, Papais-Alvarenga M, Batista E, Paiva CA, Santos CM, Vasconcelos CC.

J Neurol Sci. 2015 Jun 19. pii: S0022-510X(15)00375-5. doi: 10.1016/j.jns.2015.06.034. [Epub ahead of print]

PMID:
26115914
11.

Variants of Interferon Regulatory Factor 5 are Associated with Neither Neuromyelitis Optica Nor Multiple Sclerosis in the Southeastern Han Chinese Population.

Liu QB, Wu L, Zhao GX, Cai PP, Li ZX, Wu ZY.

Chin Med J (Engl). 2015 Jul 5;128(13):1743-7. doi: 10.4103/0366-6999.159347.

12.

Experimental models of neuromyelitis optica: current status, challenges and future directions.

Li M, Yan Y.

Neurosci Bull. 2015 Jun 24. [Epub ahead of print]

PMID:
26109280
13.

Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Pittock SJ, Lucchinetti CF.

Ann N Y Acad Sci. 2015 Jun 10. doi: 10.1111/nyas.12794. [Epub ahead of print]

PMID:
26096370
14.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG.

Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19. Review.

PMID:
26092914
15.

Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.

Kawachi I, Nishizawa M.

Neuropathology. 2015 Jun 16. doi: 10.1111/neup.12216. [Epub ahead of print]

PMID:
26079808
16.

Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.

Lee JD, Guimond C, Yee IM, Vilariño-Güell C, Wu ZY, Traboulsee AL, Sadovnick AD.

Can J Neurol Sci. 2015 Jul;42(4):235-41. doi: 10.1017/cjn.2015.36. Epub 2015 Jun 15.

PMID:
26074012
17.

Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report.

Sahraian MA, Moghadasi AN, Owji M, Naghshineh H, Minagar A.

J Med Case Rep. 2015 Jun 10;9:137. doi: 10.1186/s13256-015-0613-9.

18.
19.

Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis.

Sugiyama A, Mori M, Masuda H, Uchida T, Muto M, Uzawa A, Ito S, Kuwabara S.

J Neurol Sci. 2015 Aug 15;355(1-2):147-9. doi: 10.1016/j.jns.2015.06.004. Epub 2015 Jun 3.

PMID:
26055314
20.

Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review.

Pereira WL, Reiche EM, Kallaur AP, Kaimen-Maciel DR.

J Neurol Sci. 2015 Aug 15;355(1-2):7-17. doi: 10.1016/j.jns.2015.05.034. Epub 2015 May 31. Review.

PMID:
26050520
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk